ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 22 filers reported holding ARIDIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $142 | -29.7% | 646,000 | 0.0% | 0.00% | – |
| Q1 2023 | $202 | -70.2% | 646,000 | +12.3% | 0.00% | -100.0% |
| Q4 2022 | $678 | -99.9% | 575,000 | +1.4% | 0.00% | +100.0% |
| Q3 2022 | $527,000 | -15.4% | 567,200 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $623,000 | -38.6% | 567,200 | -1.7% | 0.00% | 0.0% |
| Q1 2022 | $1,015,000 | +2059.6% | 577,200 | +2757.4% | 0.00% | – |
| Q4 2021 | $47,000 | – | 20,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VICTORY CAPITAL MANAGEMENT INC | 934 | $6,000 | 0.00% |
| UBS Group AG | 1,025 | $7,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 300 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 25,569 | $171,000 | 0.00% |
| MORGAN STANLEY | 229 | $2,000 | 0.00% |
| BlackRock Inc. | 1,222 | $8,000 | 0.00% |
| VANGUARD GROUP INC | 81,966 | $551,000 | 0.00% |